Stericycle, Inc. (NASDAQ:SRCL) Receives $74.00 Consensus Price Target from Analysts

Shares of Stericycle, Inc. (NASDAQ:SRCL) have been given an average rating of “Hold” by the six analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $74.00.

SRCL has been the subject of several recent analyst reports. Keefe, Bruyette & Woods upped their price target on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. StockNews.com initiated coverage on Stericycle in a research note on Wednesday, September 25th. They set a “hold” rating on the stock. Royal Bank of Canada reissued a “sector perform” rating and issued a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Finally, Truist Financial increased their target price on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th.

Institutional Trading of Stericycle

Several institutional investors and hedge funds have recently made changes to their positions in SRCL. Pentwater Capital Management LP bought a new stake in Stericycle in the second quarter valued at approximately $83,010,000. Magnetar Financial LLC bought a new position in Stericycle in the second quarter valued at $81,596,000. Millennium Management LLC grew its stake in Stericycle by 1,057.6% in the second quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider’s stock valued at $76,457,000 after purchasing an additional 1,201,653 shares in the last quarter. Alpine Associates Management Inc. bought a new stake in Stericycle during the second quarter worth $62,298,000. Finally, Capital Research Global Investors lifted its stake in Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock valued at $296,762,000 after purchasing an additional 705,586 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

Stericycle Trading Up 0.1 %

Shares of NASDAQ:SRCL opened at $60.95 on Monday. Stericycle has a 1-year low of $37.78 and a 1-year high of $61.77. The company has a 50 day moving average price of $59.63 and a 200 day moving average price of $55.17. The stock has a market capitalization of $5.66 billion, a price-to-earnings ratio of -277.05, a PEG ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. The company had revenue of $661.60 million during the quarter, compared to analyst estimates of $672.07 million. On average, research analysts anticipate that Stericycle will post 2.29 EPS for the current fiscal year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.